Therapeutic Target Discovery

Scientists use PandaOmics, an AI-driven target identification tool, to examine the expression profiles of direct iPSC-derived motor neurons from Answer Amyotrophic Lateral Sclerosis (ALS) and central nervous system samples from public datasets. The discovery of novel therapy regimens is urgently needed for the severe neurological disease amyotrophic lateral sclerosis, which has unclear pathophysiology. Here, the…